Podocyte-specific GOLM1 ablation prevents, while podocyte-specific GOLM1 overexpression facilitates diabetes-related inflammation, oxidative damage, apoptosis, and renal dysfunction in vivo and in vitro. The gene discussed is GOLM1; the disease is diabetes mellitus.